Category: Gastrointestinal
Gastrointestinal
EndoGastric Solutions Inc., which makes tissue-stapling equipment for the stomach and esophagus, drums up a $30 million Series F round, while Aptus EndoSystems Inc. reels in a $15 million Series AA round.
California-based EndoGastric Solutions Inc. and Aptus EndoSystems Inc. brought in $30 million and $15 million, respectively, in separate funding rounds.
Menlo Park, Calif.-based Canaan Partners and New York-based Radius Ventures led EndoGastric's $30 million Series F round, which was designed to support the company through profitability, according to a press release.
8 Sound Shore Drive, Suite 160
Product(s):
Manufactures and markets Secca and Stretta, innovative RF treatments for bowel incontinence and reflux disease.
Boston Scientific Corp. is touting a study showing that endoscopic duodenal stenting may reduce costs and lessen hospital stays for patients with malignant gastric outlet obstruction, compare with surgical gastrojejunostomy.
Boston Scientific Corp. (NYSE:BSX) said a study of endoscopic duodenal stenting showed that the procedure reduced the cost and duration of hospital stays by about half when compared to surgical gastrojejunostomy for the treatment of malignant gastric outlet obstruction.
The research used a Medicare database to compare hospitalizations for endoscopic stenting with those for surgical GJ for the disease between 2006 and 2008.
Torax Medical Inc. wins CE Mark approval in the European Union for its Linx device, which is designed to treat gastro-esophageal reflux disease.
By Brandon Glenn
Torax Medical Inc. won CE Mark approval in the European Union for an implantable device that treats patients suffering from acid-reflux disease.
The Food & Drug Administration issues a warning letter to OST Medical Inc., its second since 2004.
The Food & Drug Administration sent another warning letter to OST Medical Inc., accusing the Warwick, R.I.-based firm violating requirements for manufacturing medical devices.
The federal watchdog agency first warned OST in July 2004, after inspections earlier that year revealed "serious regulatory problems" involving its Sentinel enteral feeding pumps. Although the company received 510(k) clearance in 2001, according to the first warning letter, the FDA found that "the device you are currently marketing is not the device described in the premarket notification" OST received in 2001.
Radio Guy Steve Erenberg's collection of unusual medical curios; anastomosis system uses biodegradable nitinol rings; ingestible robot prowls the GI; and a cochlear hearing aid without the implant.
Historic medical models and devices: Check out Radio Guy Steve Erenberg's collection of unusual medical curios, like this mechanical aluminum prosthetic. The collection ranges from orthodontic models resembling Robocop to an antique rubber "death mask" to, well, we couldn't quite figure out just what that was. 
The CEO of Mederi Therapeutics on the challenges of increasing awareness of bowel incontinence and his company's minimally invasive alternative to colostomy surgery.
How do you get people to talk to their doctors about something so embarrassing they'll barely admit it to themselves?
That's the challenge facing Greenwich, Conn.-based medical device startup Mederi Therapeutics and the minimally invasive treatment for fecal incontinence it says will eliminate the need for drastic colostomy procedures.
